Loading stock data…
SHPH
$0.69-0.34 (-32.84%)
Market ClosedLast close May 1
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Shuttle Pharmaceuticals Holdings, Inc. in the Healthcare sector is trading at $0.69. The stock is currently near its 52-week low of $0.50, remaining 69.9% below its 200-day moving average. Technical signals show neutral RSI of 48 and bearish MACD signal, explaining why SHPH maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 48) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.69
Potential Upside
5%
Whystock Fair Value$0.73
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.03M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.72
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-121.39%
Volume
Today's trading volume
18.17M
Recent News
Shuttle to Acquire United Dogecoin in Push to Build Public DOGE Mining Platform
Shuttle Pharmaceuticals Holdings (NASDAQ: $SHPH) said it has signed a definitive merger agreement to acquire United...
Shuttle Pharma Layers AI Into Its Big Oncology Push
This pharma name is betting AI can shave time, cost, and guesswork out of cancer drug development [Sponsored Post]
Shuttle Pharmaceuticals says reverse stock split to become effective June 16
Shuttle Pharmaceuticals (SHPH) announced that the reverse stock split will become effective on June 16, at 12:01 a.m., Eastern Time. The company’s common stock will continue to trade on The Nasdaq Capital Market under the existing symbol “SHPH” and will begin trading on a split-adjusted basis when the market opens on June 16. At the effective time of the reverse stock split, every 25 shares of the company’s issued and outstanding common stock will be automatically reclassified and combined into